{"id":"https://openalex.org/W2983177506","doi":"https://doi.org/10.1182/blood-2019-123068","title":"Pevonedistat, a Nedd-8 Activating Enzyme Inhibitor, Upregulates NOXA to Increase Effectiveness of Azacitidine and Venetoclax in Preclinical Models of Acute Myelogenous Leukemia","display_name":"Pevonedistat, a Nedd-8 Activating Enzyme Inhibitor, Upregulates NOXA to Increase Effectiveness of Azacitidine and Venetoclax in Preclinical Models of Acute Myelogenous Leukemia","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2983177506","doi":"https://doi.org/10.1182/blood-2019-123068","mag":"2983177506"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-123068","doi":"https://doi.org/10.1182/blood-2019-123068","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123068","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065327189","display_name":"Brianna N. Smith","orcid":"https://orcid.org/0000-0002-6905-9196","observed_orcids":["https://orcid.org/0000-0002-6905-9196"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brianna N Smith","raw_affiliation_strings":["Department of Medicine; Department of Pediatrics; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN","Department of Medicine","Department of Pediatrics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine; Department of Pediatrics; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"Department of Pediatrics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018151108","display_name":"Dan Cojocari","orcid":"https://orcid.org/0000-0002-2614-071X","observed_orcids":["https://orcid.org/0000-0002-2614-071X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Cojocari","raw_affiliation_strings":["Discovery Oncology, AbbVie Inc, North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, AbbVie Inc, North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013115443","display_name":"Julie J. Purkal","orcid":"https://orcid.org/0000-0001-8429-0313","observed_orcids":["https://orcid.org/0000-0001-8429-0313"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie J Purkal","raw_affiliation_strings":["Oncology Discovery, AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Discovery, AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061092393","display_name":"Maria Pia Arrate","orcid":"https://orcid.org/0009-0005-3292-7489","observed_orcids":["https://orcid.org/0009-0005-3292-7489"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Arrate","raw_affiliation_strings":["Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086110064","display_name":"Haley Elizabeth Ramsey","orcid":"https://orcid.org/0009-0007-1201-250X","observed_orcids":["https://orcid.org/0009-0007-1201-250X"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haley E. Ramsey","raw_affiliation_strings":["Department of Medicine and Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN","Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088427493","display_name":"Joel D. Leverson","orcid":"https://orcid.org/0000-0003-1162-724X","observed_orcids":["https://orcid.org/0000-0003-1162-724X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel D. Leverson","raw_affiliation_strings":["AbbVie Inc., North Chicago,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago,","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016707540","display_name":"Erwin R. Boghaert","orcid":"https://orcid.org/0000-0001-8242-6440","observed_orcids":["https://orcid.org/0000-0001-8242-6440"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erwin Boghaert","raw_affiliation_strings":["Oncology Discovery, AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Discovery, AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019593738","display_name":"Darren C. Phillips","orcid":"https://orcid.org/0009-0000-6760-9759","observed_orcids":["https://orcid.org/0009-0000-6760-9759"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darren C. Phillips","raw_affiliation_strings":["Discovery Oncology, AbbVie Inc., North Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Oncology, AbbVie Inc., North Chicago, IL","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Department of Medicine and Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN","Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"1380","last_page":"1380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pevonedistat","display_name":"pevonedistat","score":0.9580000042915344},{"id":"https://openalex.org/keywords/pmaip1","display_name":"Noxa","score":0.871999979019165},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8899999856948853},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9350000023841858},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.9869999885559082},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.7459999918937683},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.8140000104904175},{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.7450000047683716},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.32499998807907104},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.6800000071525574},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6209999918937683},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8791583776473999},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7920481562614441},{"id":"https://openalex.org/C9583187","wikidata":"https://www.wikidata.org/wiki/Q7919510","display_name":"Ven","level":2,"score":0.6007282733917236},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.5876690745353699},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5858915448188782},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5162741541862488},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5131836533546448},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.44232454895973206},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4169689118862152},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39322686195373535},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3217775225639343},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.26908883452415466},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.12311437726020813},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.08993878960609436},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08822762966156006},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-123068","doi":"https://doi.org/10.1182/blood-2019-123068","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123068","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3155492019","https://openalex.org/W2987022376","https://openalex.org/W3213224209","https://openalex.org/W3094649395","https://openalex.org/W4283317968","https://openalex.org/W4393948081","https://openalex.org/W4310120267","https://openalex.org/W3211541213","https://openalex.org/W7126176047","https://openalex.org/W2604878648"],"abstract_inverted_index":{"Introduction:":[0],"Venetoclax":[1],"(VEN),":[2],"a":[3,66,118,223,260,289,442],"selective":[4,157],"BCL-2":[5,21,261],"inhibitor,":[6],"has":[7,59,160,185,242],"yielded":[8],"exceptional":[9],"response":[10,363],"rates":[11],"in":[12,62,72,90,104,154,168,171,174,182,248,283,288,323,337,350,352,375,392,423,449,500,547,601,648],"patients":[13,89,111,122],"with":[14,43,74,113,156,250,286,292,304,312,320,364],"acute":[15],"myeloid":[16,139],"leukemia":[17],"(AML).":[18],"VEN":[19,58,114,134,153,198,287,308],"binds":[20],"to":[22,38,133,146,187,245,267,295,430,435],"directly":[23],"inhibit":[24],"sequestration":[25],"of":[26,87,109,121,131,138,179,197,226,326,373,396,439,471,480,503,518,527,550,572,581,604,619,628,651,660,680,692,705,719,736,747],"pro-apoptotic":[27],"proteins":[28],"such":[29],"as":[30,65,149,222],"the":[31,107,183,216,321,324,365,398,411,417,447,501,548,602,649],"activator":[32],"BIM.":[33],"Free":[34],"BIM":[35],"can":[36],"bind":[37],"BAX,":[39],"enabling":[40],"its":[41],"oligomerization":[42],"BAK,":[44],"mitochondrial":[45],"outer":[46],"membrane":[47],"permeabilization":[48],"(MOMP)":[49],"and":[50,117,173,194,206,241,255,307,310,329,413,441,467,487,514,534,568,588,615,635],"subsequent":[51],"apoptosis":[52],"(PMID":[53,97,125,190,202,239,252,270],"24074954,":[54],"9687260,":[55],"19641500,":[56],"20164920).":[57],"limited":[60],"efficacy":[61,178,293],"relapsed-refractory":[63],"AML":[64,105,110,169,299,339,376,424,452],"single":[67],"agent,":[68],"but":[69,177],"when":[70],"used":[71],"combination":[73,155,181,249,284,291,367,401,419,448],"DNA":[75],"methyltransferase":[76],"inhibitors":[77,159],"(DNMTi;":[78],"5'azacitidine-AZA-or":[79],"decitabine)":[80],"or":[81,410,558,662,682,694,707,721,738,749],"low-dose":[82],"cytosine":[83],"arabinoside":[84],"(LDAC),":[85],"50-70%":[86],"untreated":[88],"recent":[91],"clinical":[92,443],"trials":[93],"achieved":[94],"complete":[95],"remission":[96],"27520294,":[98],"30361262,":[99,126],"30892988).":[100,127],"Despite":[101],"this":[102,180,384,437,491,538,592,639],"progress":[103],"therapy,":[106],"majority":[108,325],"treated":[112,303],"ultimately":[115],"relapse,":[116],"large":[119],"subset":[120],"never":[123],"respond":[124,429],"One":[128],"postulated":[129,280],"route":[130],"resistance":[132,199],"is":[135,265],"cellular":[136],"upregulation":[137],"cell":[140,300,327,355,377],"leukemia-1":[141],"protein":[142,233],"(MCL-1),":[143],"which,":[144],"similarly":[145],"BCL-2,":[147],"functions":[148],"an":[150,353,657,677,689,702,716,733,744],"anti-apoptotic":[151],"protein.":[152],"MCL-1":[158,269],"demonstrated":[161,379],"added":[162],"benefit":[163],"over":[164],"either":[165,407],"agent":[166,408],"alone":[167,409],"cells":[170,425],"vitro":[172],"xenograft":[175,357],"models":[176,395],"clinic":[184],"yet":[186],"be":[188,421],"reported":[189],"30185627).":[191],"Both":[192],"MCL-1-dependent":[193],"MCL-1-independent":[195],"mechanisms":[196],"are":[200,213,453,469,478,516,525,570,579,617,626],"emerging":[201],"31048321,":[203],"30148320,":[204],"31262744)":[205],"new":[207],"approaches":[208],"aimed":[209],"at":[210],"addressing":[211],"these":[212,388],"moving":[214],"toward":[215],"clinic.":[217],"Pevonedistat":[218],"(PEV)":[219],"was":[220],"developed":[221],"targeted":[224],"inhibitor":[225],"NEDD-8":[227],"activating":[228],"enzyme":[229],"(NAE),":[230],"which":[231,426],"disrupts":[232],"turnover":[234],"mediated":[235],"by":[236,495,542,596,643],"Cullin-RING":[237],"ligases":[238],"19360080)":[240],"been":[243],"shown":[244],"have":[246],"activity":[247,319,405],"AZA":[251,256,306],"29348128).":[253],"PEV":[254],"both":[257],"upregulate":[258],"NOXA,":[259],"family":[262],"member":[263],"that":[264,281,380],"known":[266],"suppress":[268],"26045051,":[271],"Jin,":[272],"Cojocari,":[273],"Purkal":[274],"et":[275],"al.,unpublished":[276],"data),":[277],"so":[278],"we":[279],"PEV/AZA":[282],"synergizes":[285],"triple":[290,400],"superior":[294],"VEN/AZA":[296,414,431],"alone.":[297,432],"Methods/Results:":[298],"lines":[301,328,378],"were":[302,335,348,493,540,594,641],"PEV,":[305],"alone,":[309],"compared":[311,349],"various":[313],"VEN/PEV/AZA":[314],"combinations":[315,347],"revealing":[316],"improved":[317,362],"combinatorial":[318],"triplet":[322],"associated":[330],"NOXA":[331,381],"induction.":[332],"Similar":[333],"results":[334,389],"seen":[336],"primary":[338],"patient":[340],"samples":[341],"ex":[342],"vivo":[343,351],"(Figure":[344,368],"1).":[345],"These":[346],"OCI-AML2":[354],"line":[356],"model,":[358],"also":[359],"illustrating":[360],"significantly":[361],"PEV/AZA/VEN":[366,399],"2).":[369],"CRISPR/Cas":[370],"9":[371],"deletion":[372,382],"PMAIP1":[374],"abrogates":[383],"synergy.":[385],"Discussion:":[386],"Together,":[387],"demonstrate":[390],"that,":[391],"several":[393],"pre-clinical":[394],"AML,":[397],"provides":[402],"stronger":[403],"anti-tumorigenic":[404],"than":[406],"VEN/PEV":[412],"combinations.":[415],"Importantly,":[416],"three-drug":[418],"may":[420],"effective":[422],"do":[427],"not":[428],"Further":[433],"studies":[434],"delineate":[436],"mechanism":[438],"action,":[440],"trial":[444],"(NCT03862157)":[445],"testing":[446],"newly":[450],"diagnosed":[451],"underway.":[454],"Figure":[455],"1":[456],"Disclosures":[457],"Cojocari:":[458],"AbbVie":[459,481,497,528,544,582,598,629,645],"Inc:":[460,507,554,561,608],"Employment,":[461,508,555,562,609],"Other:":[462,509,556,563,610],"DC,":[463,510,564,611],"JP,":[464,473,511,520,565,574,612,621],"ERB,":[465,474,512,521,566,575,613,622],"JDL,":[466,513,567,614],"DCP":[468,477,515,524,569,578,616,625],"employees":[470,517,571,618],"AbbVie.":[472,496,519,543,573,597,620,644],"JDL":[475,522,576,623],"&":[476,523,577,624,671],"stockholders":[479,526,580,627],"Inc.":[482,498,529,545,583,599,630,646],"The":[483,530,584,631],"design":[484,531,585,632],"study":[485,532,586,633],"conduct,":[486,533,587,634],"financial":[488,535,589,636],"support":[489,536,590,637],"for":[490,537,591,638],"research":[492,539,593,640],"provided":[494,541,595,642],"participated":[499,546,600,647],"interpretation":[502,549,603,650],"data,":[504,551,605,652],"review.":[505,552,606,653],"Purkal:AbbVie":[506],"Leverson:AbbVie":[553],"Stock":[557],"options.":[559],"Boghaert:AbbVie":[560],"Phillips:AbbVie":[607],"Savona:AbbVie:":[654],"Membership":[655,675,687,700,714,731,742],"on":[656,676,688,701,715,732,743],"entity's":[658,678,690,703,717,734,745],"Board":[659,679,691,704,718,735,746],"Directors":[661,681,693,706,720,737,748],"advisory":[663,683,695,708,722,739,750],"committees;":[664,684,740],"Sunesis:":[665],"Research":[666,697,710,724],"Funding;":[667,698,711,725],"Boehringer":[668],"Ingelheim:":[669],"Patents":[670],"Royalties;":[672],"Celgene":[673],"Corporation:":[674,713],"TG":[685],"Therapeutics:":[686,727],"committees,":[696,709,723],"Takeda:":[699],"Incyte":[712],"Karyopharm":[726],"Consultancy,":[728],"Equity":[729],"Ownership,":[730],"Selvita:":[741],"committees.":[751]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2019-11-22T00:00:00"}